Using HER2-specific LVs carrying NanoLuc-miniSOG gene we achieved significant regression (TGI 67%) of HER2-positive xerograph tumor in the animal model, confirming a high efficiency of the proposed concept. Here, ERBB2 is linked to neoplasm.